...
首页> 外文期刊>Nanomaterials >Loading of Indocyanine Green within Polydopamine-Coated Laponite Nanodisks for Targeted Cancer Photothermal and Photodynamic Therapy
【24h】

Loading of Indocyanine Green within Polydopamine-Coated Laponite Nanodisks for Targeted Cancer Photothermal and Photodynamic Therapy

机译:聚多巴胺涂层Laponite纳米磁盘中吲哚菁绿的负载量用于靶向癌症的光热和光动力疗法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The combination of photothermal therapy (PTT) and photodynamic therapy (PDT) in cancer treatment has attracted much attention in recent years. However, developing highly efficient and targeted therapeutic nanoagents for amplifying PTT and PDT treatments remains challenging. In this work, we developed a novel photothermal and photodynamic therapeutic nanoplatform for treatment of cancer cells overexpressing integrin α v β 3 through the coating of polydopamine (PDA) on indocyanine green (ICG)-loaded laponite (LAP) and then further conjugating polyethylene glycol-arginine-glycine-aspartic acid (PEG-RGD) as targeted agents on the surface. The ICG/LAP–PDA–PEG–RGD (ILPR) nanoparticles (NPs) formed could load ICG with a high encapsulation efficiency of 94.1%, improve the photostability of loaded ICG dramatically via the protection of PDA and LAP, and display excellent colloidal stability and biocompatibility due to the PEGylation. Under near-infrared (NIR) laser irradiation, the ILPR NPs could exert enhanced photothermal conversion reproducibly and generate reactive oxygen species (ROS) efficiently. More importantly, in vitro experiments proved that ILPR NPs could specifically target cancer cells overexpressing integrin α v β 3 , enhance cellular uptake due to RGD-mediated targeting, and exert improved photothermal and photodynamic killing efficiency against targeted cells under NIR laser irradiation. Therefore, ILPR may be used as effective therapeutic nanoagents with enhanced photothermal conversion performance and ROS generating ability for targeted PTT and PDT treatment of cancer cells with integrin α v β 3 overexpressed.
机译:近年来,光热疗法(PTT)和光动力疗法(PDT)在癌症治疗中的结合引起了广泛的关注。然而,开发用于扩增PTT和PDT治疗的高效且靶向的治疗纳米剂仍然具有挑战性。在这项工作中,我们开发了一种新型的光热和光动力治疗性纳米平台,用于通过在负载吲哚花绿(ICG)的合成锂皂石(LAP)上涂覆聚多巴胺(PDA)来治疗过表达整联蛋白αvβ3的癌细胞,然后进一步偶联聚乙二醇-精氨酸-甘氨酸-天冬氨酸(PEG-RGD)作为表面上的靶向剂。形成的ICG / LAP–PDA–PEG–RGD(ILPR)纳米颗粒(NPs)可以以94.1%的高封装效率负载ICG,通过保护PDA和LAP显着提高负载的ICG的光稳定性,并显示出出色的胶体稳定性由于聚乙二醇化而具有生物相容性。在近红外(NIR)激光辐照下,ILPR NPs可再现地发挥增强的光热转化作用,并有效地产生活性氧(ROS)。更重要的是,体外实验证明ILPR NPs可以特异性靶向过度表达整联蛋白αvβ3的癌细胞,由于RGD介导的靶向作用而提高细胞摄取,并在NIR激光照射下对靶细胞发挥更好的光热和光动力杀伤效率。因此,ILPR可用作具有增强的光热转化性能和ROS产生能力的有效的治疗性纳米剂,用于靶向用整合素αvβ3过表达的PTT和PDT治疗癌细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号